Thalidomide for managing cancer cachexia

Author:

Reid Joanne1,Mills Moyra2,Cantwell Marie M3,Cardwell Chris R3,Murray Liam J4,Donnelly Michael3

Affiliation:

1. School of Nursing and Midwifery; Queen's University Belfast; Belfast UK

2. Northern Health and Social Care Trust; Antrim UK

3. Centre for Public Health; Queen's University Belfast; Belfast UK

4. Cancer Epidemiology and Health Services Research Group; Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast; Belfast UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference66 articles.

1. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial;Gordon;GUT,2005

2. Randomised phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia;Mantovani;The Oncologist,2010

3. Poor tolerability of thalidomide in end-stage oesophageal cancer;Wilkes;European Journal of Cancer Care,2011

4. Thalidmode induced cessation of weight loss and improved sleep in advanced cancer patients with cachexia;Boasberg;American Society Clinical Oncology,2000

5. Thalidomide in patients with cachexia due to terminal cancer: Preliminary report;Bruera;Annals of Oncology,1999

Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3